© 2026

For assistance accessing the Online Public File for KAXE or KBXE, please contact: Steve Neu, IT Engineer, at 800-662-5799.
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Neurontin

By Snigdha Prakash
Published October 28, 2002 at 11:00 PM CST

Snigdha Prakash reports on new documents showing that drug giant Parke Davis promoted the use of neurontin for pain treatment, even though it was not approved by the FDA for that use. Documents come from a trial underway in federal court in Boston.

Copyright 2002 NPR
Snigdha Prakash
Pieces by National Desk reporter Snigdha Prakash can be heard on NPR's All Things Considered and Morning Edition. The majority of Snigdha's past reports have focused on topics related to entrepreneurship, business, banking and the economy.
Creative Commons License
Our stories may be republished online or in print under Creative Commons license CC BY-NC-ND 4.0. We ask that you edit only for style or to shorten, provide proper attribution and link to our site. Please see our republishing guidelines for use of any other photos and graphics.